| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 1,588,086 | 1,573,957 | 1,664,247 | 1,508,277 | | Cost of Revenue | 757,765 | 748,312 | 798,809 | 709,134 | | | Gross Profit | 830,321 | 825,645 | 865,438 | 799,143 | | | Operating Expenses | | Research Development | 53,168 | 50,000 | 47,301 | 47,691 | | Selling General and Administrative | 497,689 | 496,495 | 513,871 | 479,772 | | Non Recurring | 18,815 | 17,093 | 260,093 | 3,920 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 260,649 | 262,057 | 44,173 | 267,760 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 9,049 |
-
| | Earnings Before Interest And Taxes | 260,649 | 262,057 | 53,222 | 267,760 | | Interest Expense | 54,127 | 58,777 | 70,886 | 60,386 | | Income Before Tax | 206,522 | 203,280 | (17,664) | 207,374 | | Income Tax Expense | 70,386 | 75,547 | 45,656 | 73,272 | | Minority Interest | (4,796) | (4,798) | (4,838) | (4,862) | | | | Net Income From Continuing Ops | 131,340 | 122,935 | (68,158) | 129,240 | | | Non-recurring Events | | Discontinued Operations | (2,831) | (3,832) | 10,229 | (1,565) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 128,509 | 119,103 | (57,929) | 127,675 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $128,509 | $119,103 | ($57,929) | $127,675 |
|
7.87% Nasdaq 
Income Statement
